- Home
- SBH vs ARQT Comparison
SBH vs ARQT Comparison
Compare SBH & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBH
- ARQT
- Stock Information
- Founded
- SBH 1964
- ARQT 2016
- Country
- SBH United States
- ARQT United States
- Employees
- SBH N/A
- ARQT N/A
- Industry
- SBH Other Specialty Stores
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- SBH Consumer Discretionary
- ARQT Health Care
- Exchange
- SBH Nasdaq
- ARQT Nasdaq
- Market Cap
- SBH 1.1B
- ARQT 1.1B
- IPO Year
- SBH 2006
- ARQT 2020
- Fundamental
- Price
- SBH $11.26
- ARQT $12.68
- Analyst Decision
- SBH Buy
- ARQT Strong Buy
- Analyst Count
- SBH 6
- ARQT 5
- Target Price
- SBH $13.60
- ARQT $17.00
- AVG Volume (30 Days)
- SBH 2.1M
- ARQT 2.0M
- Earning Date
- SBH 01-30-2025
- ARQT 02-25-2025
- Dividend Yield
- SBH N/A
- ARQT N/A
- EPS Growth
- SBH N/A
- ARQT N/A
- EPS
- SBH 1.43
- ARQT N/A
- Revenue
- SBH $3,717,031,000.00
- ARQT $138,708,000.00
- Revenue This Year
- SBH $2.07
- ARQT $209.03
- Revenue Next Year
- SBH $1.58
- ARQT $49.00
- P/E Ratio
- SBH $7.80
- ARQT N/A
- Revenue Growth
- SBH N/A
- ARQT 182.84
- 52 Week Low
- SBH $9.06
- ARQT $3.11
- 52 Week High
- SBH $14.79
- ARQT $16.20
- Technical
- Relative Strength Index (RSI)
- SBH 46.00
- ARQT 43.06
- Support Level
- SBH $10.81
- ARQT $13.10
- Resistance Level
- SBH $11.48
- ARQT $14.36
- Average True Range (ATR)
- SBH 0.45
- ARQT 0.99
- MACD
- SBH 0.12
- ARQT -0.32
- Stochastic Oscillator
- SBH 85.81
- ARQT 1.95
About SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. Sally Beauty operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Colombia, Mexico, Peru, France, Ireland, Spain, Germany, and the Netherlands. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. Product offerings include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.